BIT Capital’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Other funds holding BCYC
PBA
DTC
JFG
BBA
TCM
FLAM
AC
PCH
BIT Capital's BCYC Position: Q4 2023 in Review
BIT Capital sold out of Bicycle Therapeutics (BCYC) in Q4 2023, closing a stake of 4,850 shares — an estimated $97.4K sold.
BIT Capital first reported a position in BCYC in Q2 2023 and held it in 2 quarters. The position peaked at $124K in Q2 2023. 101 funds tracked by Wall St. Rank hold BCYC as of Q4 2023.
- BIT Capital reported no remaining Bicycle Therapeutics position as of Q4 2023 after selling out during the quarter.
- BIT Capital sold 4,850 Bicycle Therapeutics shares in Q4 2023, an estimated $97.4K.
- BIT Capital first reported a position in Bicycle Therapeutics in Q2 2023 and held it in 2 quarters.
- BIT Capital's Bicycle Therapeutics position peaked at $124K in Q2 2023.
- 101 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2023.
Based on BIT Capital's 13F filing for Q4 2023, filed 12 Feb 2025.